Prognostic value of plasma EBV DNA for nasopharyngeal cancer patients during treatment with intensity-modulated radiation therapy and concurrent chemotherapy. Radiol Oncol [Internet]. 2018 May 23 [cited 2026 Sep. 23];52(2). Available from: https://www.radioloncol.com/index.php/ro/article/view/2974